IL6 and cancer: Hyperactivation of IL6/STAT3 signaling in the muscle may stimulate the synthesis and systemic release of the acute-phase response proteins such as serum amyloid A (SAA) and fibrinogen, which may amplify catabolic signals in the muscle, turning muscle into a key player in innate immunity in experimental cancer-induced muscle wasting in mice (82).